| 1 |
Clinical Conference Behavioral treatment of insomnia: a clinical case series study. 2000
Perlis M, Aloia M, Millikan A, Boehmler J, Smith M, Greenblatt D, Giles D. · Sleep Disorders Center of Rochester, Behavioral Sleep Medicine Clinic, New York, USA. · J Behav Med. · Pubmed #10833677 No free full text.
Abstract: There is substantial experimental evidence that behavioral treatment of insomnia produces significant clinical improvement and that treatment gains tend to be maintained over time. Less clear is whether behavioral treatment is effective as it is plied in clinical settings. In this clinical case series study, we evaluated 47 patients with primary insomnia. It was found that patients were, on average, 43% improved. This average corresponded to a 65% reduction in sleep latency, a 46% decrease in number of awakenings per night, a 48% reduction in wake time after sleep onset, and a 13% increase in total sleep time. These results suggest that behavioral treatment for insomnia is as effective in clinical settings as it is as under clinical trial conditions.
|
| 2 |
Article Behavioral treatment of insomnia: treatment outcome and the relevance of medical and psychiatric morbidity. 2001
Perlis ML, Sharpe M, Smith MT, Greenblatt D, Giles D. · Sleep Disorders Center, Behavioral Sleep Medicine Clinic, Rochester, New York, USA. · J Behav Med. · Pubmed #11436547 No free full text.
Abstract: Recently, we undertook a case series study and found that behavior therapy for insomnia was effective as plied in the clinic setting and that the findings were similar to those in the "clinical trial" literature. In the present study, we evaluate a second set of case series data to assess (1) the replicability of our original findings, (2) if our treatment outcomes are statistically comparable to those in the literature, and (3) if medical and psychiatric morbidity influence treatment outcome. It was found that patients who completed four or more sessions of cognitive behavioral therapy for insomnia (CBT) were, on average, 33% improved. This average corresponded to a 56% reduction in wake time after sleep onset, a 34% reduction in sleep latency, a 29% increase in total sleep time, and a 13% decrease in number of awakenings per night. These findings are not significantly different from those reported in literature for both CBT and pharmacotherapy interventions. Medical and psychiatric comorbidity did not influence treatment outcome.
|
|
|